Harmony Biosciences Holdings (HRMY) Interest Coverage Ratio (2019 - 2026)
Harmony Biosciences Holdings (HRMY) reported Interest Coverage Ratio of 11.22 for Q1 2026, up 256.7% on a YoY basis from 3.15 in Q1 2025, and up 3.18% sequentially from 10.87 in Q4 2025.
Harmony Biosciences Holdings (HRMY) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings (HRMY) has 8 years of Interest Coverage Ratio data on file, last reported at 11.22 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 256.7% year-over-year to 11.22; the trailing twelve-month figure through Mar 2026 stood at 10.01 (down 8.24% YoY), and the FY2025 full-year result was 4.01, down 7.99% from the prior year.
- Interest Coverage Ratio rose to 11.22 in Q1 2026, from 10.87 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 13.24 in Q4 2024 to a low of 0.5 in Q3 2022.
- A 5-year average of 4.07 and a median of 2.18 in 2024 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio surged 442.05% in 2023 and plunged 68.66% in 2024, its largest moves.
- Tracing HRMY's Interest Coverage Ratio over 5 years: stood at 7.12 in 2022, then retreated by 28.17% to 5.12 in 2023, then jumped by 158.8% to 13.24 in 2024, then slipped by 17.87% to 10.87 in 2025, then grew by 3.18% to 11.22 in 2026.
- Business Quant data shows HRMY's Interest Coverage Ratio at 11.22 in Q1 2026, 10.87 in Q4 2025, and 3.66 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Harmony Biosciences Holdings | 2.07 Bn | 1.55 Bn | 170.88 Mn | 11.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.22 |
| Dec 31, 2025 | 10.87 |
| Sep 30, 2025 | 3.66 |
| Jun 30, 2025 | 1.62 |
| Mar 31, 2025 | 3.15 |
| Dec 31, 2024 | 13.24 |
| Sep 30, 2024 | 0.85 |
| Jun 30, 2024 | 0.77 |
| Mar 31, 2024 | 2.18 |
| Dec 31, 2023 | 5.12 |
| Sep 30, 2023 | 2.71 |
| Jun 30, 2023 | 1.97 |
| Mar 31, 2023 | 1.70 |
| Dec 31, 2022 | 7.12 |
| Sep 30, 2022 | 0.50 |
| Jun 30, 2022 | 1.39 |
| Mar 31, 2022 | 1.16 |
| Dec 31, 2021 | 7.47 |
| Sep 30, 2021 | 1.13 |
| Jun 30, 2021 | 3.20 |